Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study.

J Neuroimmunol. 2010 Oct 8; 227(1-2) : 185-9. Epub 2010 Aug 21. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. Yamout B, Hourani R, Salti H, Barada W, El-Hajj T, Al-Kutoubi A, Herlopian A, Baz EK, Mahfouz R, Khalil-Hamdan R, Kreidieh NM, El-Sabban M, Bazarbachi A. Departments of Internal…

Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population.

Ann Hematol. 2010 Sep 25; Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population. Xu J, Ji BX, Su L, Dong HQ, Sun WL, Wan SG, Liu YO, Zhang P, Liu CY Abstract To evaluate clinical outcomes of autologous peripheral blood…

The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood derived stem cells.

Cell Transplant. 2010 Sep 30. doi: 10.3727/096368910X532855. The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood derived stem cells. Sanberg PR, Eve DJ, Willing AE, Garbuzova-Davis S, Tan J, Sanberg CD, Allickson JG, Cruz LE, Borlongan CV. Center Of Excellence for Aging and Brain Repair, Dept. Neurosurgery and Brain Reapir, University of…

Hematopoietic SCT for the treatment of multiple sclerosis.

Bone Marrow Transplant. 2010 Aug 9; Hematopoietic SCT for the treatment of multiple sclerosis. Atkins H Abstract Multiple sclerosis (MS) is the leading autoimmune indication for autologous hematopoietic SCT (aHSCT). Patient selection criteria and transplant interventions have been refined through a series of cohort and registry studies. High- and low-intensity chemotherapy-based conditioning regimens have been…

Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis.

2010 Aug; 16(8) : 909-18 Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis. Mallam E, Kemp K, Wilkins A, Rice C, Scolding N Abstract Recent studies have investigated the potential of autologous bone marrow-derived mesenchymal stem cells (MSCs) as a therapy for multiple sclerosis. Whether MSCs from individuals…

Cell replacement therapies to promote remyelination in a viral model of demyelination.

2010 Jul 27;224(1-2):101-7 Cell replacement therapies to promote remyelination in a viral model of demyelination. Tirotta E, Carbajal KS, Schaumburg CS, Whitman L, Lane TE Abstract Persistent infection of the central nervous system (CNS) of mice with the neuroadapted JHM strain of mouse hepatitis (MHV) is characterized by ongoing demyelination mediated by inflammatory T cells…

High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience.

2010 Jun;16(6):685-93 High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience. Krasulovã¡ E, Trneny M, Kozã¡k T, Vackovã¡ B, Pohlreich D, Kemlink D, Kobylka P, Kovã¡rovã¡ I, Lhotã¡kovã¡ P, Havrdovã¡ E Abstract There are multiple sclerosis patients who suffer from an aggressive course of the disease with…

Multiple sclerosis – established and novel therapeutic approaches.

Cent Nerv Syst Agents Med Chem. 2010 Mar; 10(1) : 3-15 Multiple sclerosis – established and novel therapeutic approaches. Ehling R, Berger T, Reindl M Abstract Multiple sclerosis (MS) is the most common disabling neurological disease in young adults characterized by recurrent relapses and / or progression that are attributable to multifocal inflammation, demyelination and…